June / May 2021

Written By Daniel Quay

• NPAC provided testimony at the Food and Drug Administration Summit on Morphine Milligram Equivalents (MMEs).

• NPAC presented Abstracts at the National Academy of Medicine Conference on Addiction.

• NPAC responded to the Agency for Healthcare Research and Quality (AHRQ) call for comment on its draft report on Integrated Pain Management Programs.

• NPAC members met with the Department of Justice Civil Rights Division on issues involving access to care and services.

• NPAC met with the White House Office of National Drug Control Policy (ONDCP).

Daniel Quay
Previous

July 2021
Next

March/April 2021